Pharma BD Deal Intelligence
The Deal Library
Browse 3,461 pharma and biotech BD deals, $5590.1B in disclosed deal value, 901 with a post-close Outcome Score, organized by year, acquirer, and therapeutic area. Each deal is graded on announcement reception and post-close outcome.
Interactive search & filters ·
How we score deals
By year
By acquirer
Abbott Laboratories (15)
AbbVie (19)
AbbVie Inc. (43)
Actavis plc (3)
Alexion Pharmaceuticals Inc. (5)
Alkermes plc (4)
Allergan (3)
Allergan plc (14)
Almirall (3)
Amgen (15)
Amgen Inc. (19)
Angelini Pharma (4)
Antengene Corporation Limited (3)
Ascentage Pharma (3)
Astellas (3)
Astellas Pharma (3)
Astellas Pharma Inc. (24)
AstraZeneca (11)
AstraZeneca PLC (61)
Bausch Health (3)
Bayer (5)
Bayer AG (31)
BeiGene Ltd. (4)
Biogen Inc. (19)
BioMarin Pharmaceutical Inc. (5)
BioNTech (5)
BioNTech SE (7)
Boehringer Ingelheim (13)
Boehringer Ingelheim GmbH (6)
Boehringer Ingelheim International GmbH (13)
Boston Scientific Corporation (5)
Bristol Myers Squibb (17)
Bristol-Myers Squibb Company (57)
Calibre Scientific (3)
Celgene Corporation (13)
Cephalon Inc. (13)
Chiesi Group (4)
Chugai Pharmaceutical Co. Ltd. (4)
Concentra Biosciences, LLC (4)
CRISPR Therapeutics (5)
CRISPR Therapeutics AG (3)
CSL Behring (3)
CSL Limited (4)
CStone Pharmaceuticals (4)
Cubist Pharmaceuticals, Inc. (4)
Daiichi Sankyo (5)
Daiichi Sankyo Company, Limited (8)
Danaher Corporation (3)
Dynavax Technologies Corporation (4)
Eisai Co., Ltd. (4)
Eli Lilly (6)
Eli Lilly and Company (101)
Endo Health Solutions Inc. (4)
Endo International plc (5)
Endo Pharmaceuticals Inc. (7)
EQRx (3)
Everest Medicines (4)
Everest Medicines Limited (4)
F. Hoffmann-La Roche AG (7)
Forest Laboratories, Inc. (3)
Fosun Pharma (3)
Genentech (12)
Genentech, Inc. (Roche Group) (10)
Genmab (3)
Genmab A/S (4)
Genzyme Corporation (6)
Gilead Sciences Inc. (26)
Gilead Sciences, Inc. (5)
Ginkgo Bioworks (6)
GlaxoSmithKline plc (26)
Grifols (3)
GSK (9)
GSK plc (33)
H. Lundbeck A/S (3)
Harbour BioMed (3)
Hikma Pharmaceuticals PLC (4)
Hologic, Inc. (3)
Horizon Pharma plc (4)
Hospira Inc. (5)
iBio, Inc. (3)
Illumina, Inc. (3)
Immunome Inc. (4)
Incyte (4)
Incyte Corporation (7)
Innovent Biologics, Inc. (7)
Inverness Medical Innovations Inc. (5)
Ipsen (7)
Ipsen S.A. (9)
Janssen Biotech (6)
Janssen Biotech, Inc. (5)
Janssen Pharmaceuticals (3)
Janssen Pharmaceuticals, Inc. (5)
Jasper Therapeutics, Inc. (3)
Jazz Pharmaceuticals PLC (5)
Jazz Pharmaceuticals plc (7)
Johnson & Johnson (32)
Kaken Pharmaceutical Co., Ltd. (3)
King Pharmaceuticals Inc. (3)
Knight Therapeutics (6)
Knight Therapeutics Inc. (5)
Lantheus Holdings, Inc. (4)
LEO Pharma A/S (4)
Lilly (11)
Lonza Group AG (3)
M8 Pharmaceuticals (4)
Madrigal Pharmaceuticals (3)
Mallinckrodt plc (7)
MedImmune (5)
Menarini Group (5)
Merck (4)
Merck & Co. Inc. (63)
Merck & Co., Inc. (3)
Merck KGaA (15)
Merck KGaA, Darmstadt, Germany (7)
Mitsubishi Tanabe Pharma Corporation (4)
MSD (8)
Mylan Inc. (5)
Mylan Laboratories Inc. (4)
Mylan N.V. (5)
Nektar Therapeutics (3)
Neurocrine Biosciences Inc. (4)
Nippon Shinyaku (5)
Novartis (15)
Novartis AG (62)
Novo Nordisk (13)
Novo Nordisk A/S (29)
Nycomed (3)
Ono Pharmaceutical (8)
Ono Pharmaceutical Co., Ltd. (9)
Orion (4)
Orion Corporation (3)
Otsuka Pharmaceutical Co., Ltd. (6)
Pathos AI, Inc. (3)
PCI Biotech (4)
Pfizer (5)
Pfizer Inc. (69)
Phio Pharmaceuticals Corp. (3)
Pierre Fabre Laboratories (3)
Processa Pharmaceuticals, Inc. (5)
Pyxis Oncology (3)
Qilu Pharmaceutical (5)
Reckitt Benckiser plc (4)
Recordati (3)
Recordati S.p.A. (3)
Regeneron Pharmaceuticals, Inc. (11)
Revolution Medicines, Inc. (3)
Roche (20)
Roche Holding AG (72)
Roivant Sciences (3)
Royalty Pharma (7)
Sanofi (10)
Sanofi S.A. (3)
Sanofi SA (55)
Sanofi-Aventis (7)
Sarepta Therapeutics (3)
Sarepta Therapeutics Inc. (6)
Schering-Plough Corp. (4)
Selecta Biosciences, Inc. (3)
Sentynl Therapeutics, Inc. (4)
SERB Pharmaceuticals (3)
Servier (18)
Servier Pharmaceuticals LLC (3)
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (3)
Shionogi & Co., Ltd. (3)
Shire plc (11)
Simcere (3)
SK Biopharmaceuticals Co., Ltd. (3)
Skye Bioscience, Inc. (3)
Sorrento Therapeutics Inc. (3)
Stryker Corporation (5)
Sumitomo Dainippon Pharma Co., Ltd. (5)
Sun Pharma (3)
Sun Pharmaceutical Industries Ltd. (6)
Swedish Orphan Biovitrum AB (6)
Taisho Pharmaceutical Co., Ltd. (3)
Takeda (6)
Takeda Pharmaceutical (3)
Takeda Pharmaceutical Company Limited (13)
Takeda Pharmaceutical Company Ltd. (25)
Teva (3)
Teva Pharmaceutical Industries Ltd. (21)
Thermo Fisher Scientific Inc. (7)
Tonix Pharmaceuticals Holding Corp. (4)
UCB (3)
UCB S.A. (5)
Ultragenyx Pharmaceutical Inc. (4)
United Therapeutics (6)
Valeant Pharmaceuticals International (4)
Valeant Pharmaceuticals International, Inc. (9)
Vertex Pharmaceuticals (3)
Vertex Pharmaceuticals Incorporated (14)
Vifor Pharma (4)
Watson Pharmaceuticals (Actavis Inc.) (9)
XOMA Royalty (3)
Zai Lab (5)
Zai Lab Limited (3)
Zimmer Holdings Inc. (3)
By therapeutic area
The Pharma Closeout — Deal Intelligence Database.
Critic Score and Outcome Score from sourced facts.
Home ·
Deals ·
Methodology ·
About